特兰胺酸是否会降低患有脑性麻的儿童接受骨切除术的输血需求? 一个系统的审查和元分析
Claudia De Dios Domínguez1, Luis Guillermo Pérez Cadena2, Manuel Gilberto Pérez Cadena2
1University of Cantabria, Santander, Spain.
Journal of orthopaedics
|July 26, 2024
概括
特兰胺酸 (TXA) 降低了整体输血率和脑的儿童进行骨切除术的总体血液损失. 然而,它可能会延长住院时间,对估计的血液损失或血红蛋白水平没有重大影响.
科学领域:
- 整形外科手术 整形外科手术
- 儿科手术 儿科手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 患有脑的儿童经常经历部位移,需要骨切除术.
- 这些手术存在很高的血损失风险,需要输血.
- 胺酸 (TXA) 是一种已知的抗纤维解质剂,有可能在手术期间减轻出血.
研究的目的:
- 评价特兰胺酸 (TXA) 降低血损失和输血需求的疗效,在接受骨切割的儿童脑患者中.
- 对现有研究进行全面的元分析,以确定TXA在这个特定患者群体中的影响.
主要方法:
- 进行了系统的元分析,包括随机对照试验和观察性队列研究,这些研究发表至2024年4月17日.
- 研究比较了TXA与对照组在接受骨切割的儿童中进行的管理.
- 主要结局是整体输血率;次要结局包括血液损失,血红蛋白/血红素水平和停留时间.
主要成果:
- 使用TXA显著降低了整体输血率 (RR=0.65) 和术后输血率 (RR=0.53).
- 随着TXA的使用,总输血 (TBL) 显著减少 (MD=-139.41).
- 一个值得注意的发现是TXA组的住院时间增加 (MD=0.47),而估计的血液损失 (EBL) 和血液学参数没有显著差异.
结论:
- 特兰胺酸有效地减少了输血需求和脑的儿童进行骨切除术的总体血液损失.
- 使用TXA可能与更长的住院时间有关.
- 可能需要进一步的研究来探索延长逗留时间的原因,并优化TXA协议.
相关概念视频
Blood Transfusion and Agglutination
10.8K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.8K
Bone Marrow Sampling and Transplants
318
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
318


